These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 39050850)

  • 1. HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis.
    Peris Sempere V; Luo G; Muñiz-Castrillo S; Pinto AL; Picard G; Rogemond V; Titulaer MJ; Finke C; Leypoldt F; Kuhlenbäumer G; ; Jones HF; Dale RC; Binks S; Irani SR; Bastiaansen AE; de Vries JM; de Bruijn MAAM; Roelen DL; Kim TJ; Chu K; Lee ST; Kanbayashi T; Pollock NR; Kichula KM; Mumme-Monheit A; Honnorat J; Norman PJ; Mignot E
    Front Immunol; 2024; 15():1423149. PubMed ID: 39050850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic Polymorphisms of
    Ureshino H; Shindo T; Kojima H; Kusunoki Y; Miyazaki Y; Tanaka H; Saji H; Kawaguchi A; Kimura S
    Cancer Immunol Res; 2018 Jun; 6(6):745-754. PubMed ID: 29695383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A and HLA-DRB1 may play a unique role in ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis.
    Zhao X; Li J; Zhu Q; Liang G; Xia W; He X; Zhu C; Qi H; Deng B; Chen X; Zhang J
    Reprod Biol Endocrinol; 2020 Nov; 18(1):107. PubMed ID: 33160385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
    Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
    J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II allele
    Shu Y; Qiu W; Zheng J; Sun X; Yin J; Yang X; Yue X; Chen C; Deng Z; Li S; Yang Y; Peng F; Lu Z; Hu X; Petersen F; Yu X
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):652-658. PubMed ID: 30636700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
    Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
    PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence.
    Ferron E; David G; Willem C; Legrand N; Salameh P; Anquetil L; Walencik A; Gendzekhadze K; Gagne K; Retière C
    Front Immunol; 2024; 15():1389358. PubMed ID: 38736873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Association Study Identifies IFIH1 and HLA-DQB1*05:02 Loci Associated With Anti-NMDAR Encephalitis.
    Liu X; Zheng X; Shu Y; Qu X; Wang Q; Liu X; Hu FY; Liu J; Lian Y; He BM; Li C; Zhou D; Qiu W; Sun L; Hong Z
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200221. PubMed ID: 38579189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
    Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
    Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA and KIR polymorphisms affect NK-cell anti-tumor activity.
    Passweg JR; Huard B; Tiercy JM; Roosnek E
    Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
    Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
    PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
    Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.
    Varbanova V; Naumova E; Mihaylova A
    Cancer Immunol Immunother; 2016 Apr; 65(4):427-40. PubMed ID: 26874942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and causative killer Ig-like receptor (KIR) and metalloproteinase genetic patterns associated with Herpes simplex virus 1 (HSV-1) encephalitis occurrence.
    Tuttolomondo A; Di Raimondo D; Vasto S; Casuccio A; Colomba C; Norrito RL; Di Bona D; Arnao V; Siciliano L; Cascio A; Pinto A;
    J Neuroimmunol; 2020 Jul; 344():577241. PubMed ID: 32334204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
    Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
    Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
    Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
    Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
    Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
    Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.